Genomic Confirmation of Borrelia garinii, United States

0567729 - BC 2024 RIV US eng J - Článek v odborném periodiku
Rudenko, Natalia - Golovchenko, Maryna - Horák, Aleš - Grubhoffer, Libor - Mongodin, E.F. - Fraser, C.M. - Qiu, W. - Luft, B. J. - Morgan, R.G. - Casjens, S.R. - Schutzer, S. E.
Genomic Confirmation of Borrelia garinii, United States.
Emerging Infectious Diseases. Roč. 29, č. 1 (2023), s. 64-69. ISSN 1080-6040. E-ISSN 1080-6059
Grant CEP: GA MZd(CZ) NV19-05-00191; GA ČR(CZ) GA21-26209S
Institucionální podpora: RVO:60077344
Klíčová slova: Genomic * Borrelia garinii * United States
Obor OECD: Immunology
Impakt faktor: 11.8, rok: 2022
Způsob publikování: Omezený přístup
https://wwwnc.cdc.gov/eid/article/29/1/22-0930_article

Lyme disease is a multisystem disorder primarily caused by Borrelia burgdorferi sensu lato. However, B. garinii, which has been identified on islands off the coast of New-foundland and Labrador, Canada, is a cause of Lyme dis-ease in Eurasia. We report isolation and whole-genome nucleotide sequencing of a B. garinii isolate from a cot-ton mouse (Peromyscus gossypinus) in South Carolina, USA. We identified a second B. garinii isolate from the same repository. Phylogenetic analysis does not associ-ate these isolates with the previously described isolates of B. garinii from Canada.
Trvalý link: https://hdl.handle.net/11104/0344204